Is penicillin allergy de-labelling about to find its place in UK antimicrobial stewardship strategy?
ORCID
- Mathew Upton: 0000-0003-4287-6396
- Bridie Kent: 0000-0001-9550-1913
Abstract
Penicillin allergy records are common, often incorrect, limit antibiotic treatment options and associated with patient and health system harm. The large numbers of patients with penicillin allergy records and the paucity of allergists have led researchers to explore non-allergist delivered assessment of penicillin allergy records and removal of those inconsistent with allergy (called de-labelling). A recent systematic review and meta-analysis of the literature concludes non-allergist delivery of penicillin allergy de-labelling to be safe and effective. Several countries outside Europe have endorsed non-allergist de-labelling and produced national guidelines and toolkits for de-labelling, but until recently the UK lacked such guidance. In September 2022 the British Society of Allergy and Clinical Immunology (BSACI) produced their guidelines endorsing non-allergist delivered penicillin allergy de-labelling. These BSACI guidelines, coupled with the ongoing NIHR funded penicillin allergy de-labelling studies, will enable this important patient safety and antimicrobial stewardship intervention to become standard of care for NHS patients.
Publication Date
2023-01-17
Publication Title
Clinical Medicine
Volume
23
Issue
1
ISSN
1470-2118
Embargo Period
2023-02-07
Keywords
antimicrobial stewardship, de-labelling, non-allergist, penicillin allergy
First Page
76
Last Page
77
Recommended Citation
Powell, N., Upton, M., Kent, B., Tonkin-Crine, S., & Sandoe, J. (2023) 'Is penicillin allergy de-labelling about to find its place in UK antimicrobial stewardship strategy?', Clinical Medicine, 23(1), pp. 76-77. Available at: 10.7861/clinmed.2022-0518
